Analyst Reco.

02/02 Sanofi Rises After Phase 3 Data and Oddo BHF Rating Zonebourse
30/01 SANOFI : Goldman Sachs reaffirms its Neutral rating ZD
30/01 Sanofi Stays at Buy at BofA on Valuation; FY25 EPS Beat, Guidance As Expected MT
30/01 SANOFI : UBS gives a Neutral rating ZD
30/01 SANOFI : Deutsche Bank reiterates its Buy rating ZD
29/01 Sanofi: More than operational delivery, markets seek pipeline answers

Alphavalue
29/01 SANOFI : JP Morgan reaffirms its Neutral rating ZD
29/01 SANOFI : Gets a Neutral rating from UBS ZD
29/01 SANOFI : Receives a Buy rating from Jefferies ZD
28/01 Vallourec, Mersen, Delfingen... Stocks to Watch Tomorrow in Paris Zonebourse
27/01 Citi Initiates Coverage of Sanofi with "Neutral" Rating Zonebourse
27/01 SANOFI : Deutsche Bank reiterates its Buy rating ZD
26/01 BofA Keeps Sanofi at Buy Following Latest Amlitelimab Data in Atopic Dermatitis MT
23/01 SANOFI : JP Morgan remains Neutral ZD
23/01 SANOFI : Barclays remains Neutral ZD
23/01 SANOFI : Jefferies maintains a Buy rating ZD
22/01 SANOFI : Buy rating from Jefferies ZD
21/01 Sanofi Kept at Buy as Berenberg Highlights Drugmaker's Top-tier Topline, Deals Firepower MT
16/01 UBS Downgrades Sanofi, Citing Lack of "Pipeline" Zonebourse
16/01 SANOFI : UBS gives a Neutral rating ZD
16/01 SANOFI : Deutsche Bank maintains a Buy rating ZD
16/01 Sector Update: Health Care Stocks Softer Late Afternoon MT
15/01 SANOFI : Barclays sticks Neutral ZD
15/01 SANOFI : Goldman Sachs remains Neutral ZD
14/01 SANOFI : JP Morgan is Neutral ZD
No results for this search